17-allylamino-17-demethoxygeldanamycin (17-AAG) abrogates the G(2)/M cell cycle checkpoint by down-regulating chk1 and selectively sensitizes tumor cells with defective p53 to topoisomerase I poison Meeting Abstract


Authors: Tse, A. N.; Solit, D.; Rosen, N.; Schwartz, G.
Abstract Title: 17-allylamino-17-demethoxygeldanamycin (17-AAG) abrogates the G(2)/M cell cycle checkpoint by down-regulating chk1 and selectively sensitizes tumor cells with defective p53 to topoisomerase I poison
Meeting Title: 40th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 22
Issue: 14 Suppl.
Meeting Dates: 2004 Jun 5-8
Meeting Location: New Orleans, LA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2004-07-15
Start Page: 212S
Language: English
ACCESSION: WOS:000223512400838
PROVIDER: wos
Notes: Meeting Abstract: 3069 -- 40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA -- S -- Source: Wos